GNFT - Nilai Wutuh Bisnis GENFIT

Genfit S.A. (GNFT) is recognized as a global authority in the therapy of liver pathologies, having earned the trust of medical professionals through fundamental research. The company is currently actively developing its portfolio of treatments for rare metabolic disorders, promoting the drug Iqirvo. Business development relies on a strong scientific staff and a European approach to management. This chart illustrating quotes with a Separate Enterprise Value of is available below.

Genfit SA - Nilai Total Perusahaan GNFT (periode 04.07.2022 - 30.10.2026)

GENFIT (GNFT) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:

Kurs saham Genfit SA|GNFT - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Biji pasar Genfit S.A.|GNFT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- indikator kapitalisasi buku:

Rega Buku Saham Genfit S.A.|GNFT - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih genfit.com|GNFT - Total Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

- rincian asil keuangan lan kelipatan valuasi:

GNFT - Penghasilan resik

Analisis kabeh metrik perusahaan:Genfit S.A.

Enterprise Value (EV) sums market capitalization and net debt, determining the actual cost of a full business buyout. By analyzing Enterprise Value dynamics, an investor can track the impact of milestone payments from partners and the success of PBH therapy on the real asset valuation of Genfit S.A. (GNFT), identifying any pricing anomalies against the backdrop of clinical achievements.

Pesaing Genfit S.A. (GNFT)